Biochemical Engineering
AstraZeneca pays Silence $60M to take siRNA beyond the liver
25th March 2020
AstraZeneca is set to pay Silence Therapeutics $60 million (€55 million) to work on siRNA therapies against cardiovascular, renal, metabolic and respiratory disease targets. The upfront cash fee is part of a suite of payments that could see Silence reel in billions of dollars through the deal. Source: Fierce Biotech 25/3/2020
Back to group news